← Back to IDYA

IDEAYA Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 06/05/2025
$8.9$6.6$208$0$0$0
−$112−$99$119−$77−$72−$52−$53−$40
−$1.22−$1.11$1.33−$0.88−$0.82−$0.60−$0.68−$0.53
9289908888867875

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.